[ZVRA] YoY Quarter Result on 30-Jun-2024 [#Q2]

Stock
[ZVRA] Zevra Therapeutics, Inc.
Announcement Date
13-Aug-2024
Financial Year
2024
Quarter
30-Jun-2024 [#Q2]
Profit Trend
QoQ- -19.87%
YoY- -291.92%
Quarter Report
ZVRA's Result
ZVRA's Financial Summary
View:
Show?
Quarter Result
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
Revenue 4,449 8,470 1,300 11,986 6,908 0 0 -
PBT -19,855 -5,158 -24,757 6,203 859 -9,266 -10,032 12.03%
Tax 70 -74 -715 -39 1,771 -9 -39 -
NP -19,925 -5,084 -24,042 6,203 834 -9,257 -9,993 12.17%
Tax Rate - - - 0.63% -206.17% - - -
Total Cost 24,374 13,554 25,342 5,783 6,074 9,257 9,993 16.00%
Ratio Analysis
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
NP Margin -447.85 -60.02 -1,849.38 51.75 12.07 0.00 0.00 -
Per Share
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
EPS -0.48 -0.15 -0.70 0.21 0.21 -5.28 -10.44 -40.11%
EPS Diluted -0.48 -0.15 -0.70 0.21 0.21 -5.22 -9.66 -39.33%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.